An experimental pain medication from Eli Lilly significantly outperformed placebo at reducing the number of weekly cluster headache attacks for patients who experience them intermittently, according to data released Tuesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,